Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Secures $1.5M in Funding for Plant Initiative

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that it has secured $1.5 million in funding from undisclosed private investors to fund a new microRNA-based plant biotechnology project.
 
The Rehovot, Israel-based firm said that it has launched Rosetta Green, which will apply the firm’s knowledge gained from conducting research on microRNA-based diagnostics and therapeutics to plant-based applications. Rosetta said that it has already found a correlation between the expression of microRNAs and algal oil content, as well as starch and oil content in corn.
 
“Stemming from their role as master regulators of gene expression, microRNAs are believed to play a critical role in each major step in plant and algal development and may therefore affect biotech-related traits such as oil and starch content, stress-tolerance, growth rate, yield, and more,” said Rudy Maor, head of R&D at Rosetta Green, in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.